tiprankstipranks
Trending News
More News >
Resmed (DE:RME)
FRANKFURT:RME
Germany Market

Resmed (RME) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Resmed’s (RME) Moving Averages Convergence Divergence (MACD) indicator is 5.44, suggesting Resmed is a Sell.
Resmed’s (RME) 20-Day exponential moving average is 207.37, while Resmed’s (RME) share price is €221.7, making it a Buy.
Resmed’s (RME) 50-Day exponential moving average is 206.47, while Resmed’s (RME) share price is €221.7, making it a Buy.

Resmed (RME) Pivot Points

May 20, 2025, 08:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
215.80
217.10
219.70
221.00
223.60
224.90
227.50
Fibonacci
217.10
218.59
219.51
221.00
222.49
223.41
224.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Resmed (RME) Moving Averages

May 20, 2025, 08:36 AM
Period
Simple
Exponential
MA5
218.03Buy
217.68Buy
MA10
212.68Buy
213.02Buy
MA20
202.02Buy
207.37Buy
MA50
202.70Buy
206.47Buy
MA100
214.86Buy
210.18Buy
MA200
216.14Buy
208.24Buy
Resmed’s (RME) 10-Day exponential moving average is 213.02, while Resmed’s (RME) share price is €221.7, making it a Buy.
Resmed’s (RME) 100-Day exponential moving average is 210.18, while Resmed’s (RME) share price is €221.7, making it a Buy.
Resmed’s (RME) stock price is €221.7 and Resmed’s (RME) 50-day simple moving average is 202.70, creating a Buy signal.
Resmed’s (RME) stock price is €221.7 and Resmed’s (RME) 100-day simple moving average is 214.86, creating a Buy signal.
Resmed’s (RME) stock price is €221.7 and Resmed’s (RME) 200-day simple moving average is 216.14, creating a Buy signal.

Resmed (RME) Technical Indicators

May 20, 2025, 08:36 AM
Name
Value
Implied Action
RSI (14)
67.17
Neutral
STOCH (9,6)
87.35
Sell
STOCHRSI (14)
94.08
Sell
MACD (12,26)
5.44
Sell
ADX (14)
23.85
Neutral
Williams %R
-12.60
Sell
CCI (14)
122.08
Sell
ATR (14)
4.73
-
Ultimate Oscillator
60.83
Neutral
ROC
19.41
Buy
Resmed’s (RME) Relative Strength Index (RSI) is 67.17, creating a Neutral signal.
Resmed’s (RME) Trend Strength Indicator (ADX) is 23.85, creating a Neutral signal.
Resmed’s (RME) Commodity Channel Index (CCI) is 122.08, creating a Sell signal.
Resmed’s (RME) Price Rate of Change (ROC) is 19.41, creating a Buy signal.

FAQ

Is RME a Buy, Hold, or Sell?
Based on RME’s technical indicators, RME is a Buy.
    What is RME’s RSI (14)?
    RME’s RSI (14) is 67.17, which suggests RME is a Neutral.
      What is RME’s MACD?
      RME’s MACD is 5.44, which suggests RME is a Sell.
        What is RME’s 5-day moving average?
        RME’s 5-day moving average is 218.03, which suggests RME is a Buy.
          What is RME’s 20-day moving average?
          RME 20-day moving average is 202.02, which suggests RME is a Buy.
            What is RME’s 50-day moving average?
            RME’s 50-day moving average is 202.70, which suggests RME is a Buy.
              What is RME’s 200-day moving average?
              RME’s 200-day moving average is 216.14, which suggests RME is a Buy.
                What is RME’s Williams % R (14)?
                RME’s Williams % R (14) is -12.60, which suggests RME is a Sell.
                  What is RME’s CCI (14)?
                  RME’s CCI (14) is 122.08, which suggests RME is a Sell.
                    What is the share price of Resmed?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis